Results 31 to 40 of about 78,570 (186)
Nature Communications, 2023 SARS-CoV-2 variants and seasonal coronaviruses continue to cause disease and coronaviruses in the animal reservoir pose a constant spillover threat. Importantly, understanding of how previous infection may influence future exposures, especially in the ...
Magen E. Francis +16 more
doaj +1 more source
Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia
Emerging Infectious Diseases, 2021 Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development.
Abeer N. Alshukairi +22 more
doaj +1 more source
Coronaviruses and their therapy
Antiviral Research, 2006 Coronaviruses may cause respiratory, enteric and central nervous system diseases in many species, including humans. Until recently, the relatively low burden of disease in humans caused by few of these viruses hampered development of coronavirus specific therapeutics.
Haagmans, Bart, Osterhaus, Ab
openaire +3 more sources
Emerging Infectious Diseases, 2006 Bats have been identified as a natural reservoir for an increasing number of emerging zoonotic viruses, including henipaviruses and variants of rabies viruses.
Lin-Fa Wang +5 more
doaj +1 more source
Vaccine Candidate Against COVID-19 Based on Structurally Modified Plant Virus as an Adjuvant
Frontiers in Microbiology, 2022 A recombinant vaccine candidate has been developed based on the major coronaviruses’ antigen (S protein) fragments and a novel adjuvant—spherical particles (SPs) formed during tobacco mosaic virus thermal remodeling.
Angelina O. Kovalenko +10 more
doaj +1 more source
Emerging Infectious Diseases, 2021 We reviewed the timeline of key policies for control of the coronavirus disease epidemic and determined their impact on the epidemic and hospital burden in South Korea. Using a discrete stochastic transmission model, we estimated that multilevel policies,
Hae-Young Kim +13 more
doaj +1 more source
Emerging Infectious Diseases, 2021 Pooled nucleic acid amplification tests for severe acute respiratory syndrome coronavirus 2 could increase availability of testing at decreased cost.
Hannah Wang +10 more
doaj +1 more source
, 2022 Abstract This chapter begins by describing older coronaviruses, such as SARS and MERS, followed by the novel coronavirus SARS-CoV-2. Details of Pfizer’s mRNA vaccine are described and viral vector vaccines are also reviewed. This chapter will also discuss two small-molecule antiviral drugs: Gilead’s remdesivir and dexamethasone.
Schoeman, Dewald +2 more
openaire +2 more sources
Back to the Future: Immune Protection or Enhancement of Future Coronaviruses
MicroorganismsBefore the emergence of SARS-CoV-1, MERS-CoV, and most recently, SARS-CoV-2, four other coronaviruses (the alpha coronaviruses NL63 and 229E and the beta coronaviruses OC43 and HKU1) had already been circulating in the human population. These circulating
Merit Bartels +3 more
doaj +1 more source
Antiviral functionalization of cellulose using tannic acid and tannin-rich extracts
Frontiers in Microbiology, 2023 Due to seasonally appearing viruses and several outbreaks and present pandemic, we are surrounded by viruses in our everyday life. In order to reduce viral transmission, functionalized surfaces that inactivate viruses are in large demand.
Marjo Haapakoski +9 more
doaj +1 more source